BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 32918990)

  • 1. Kanglaite enhances the efficacy of cisplatin in suppression of hepatocellular carcinoma via inhibiting CKLF1 mediated NF-κB pathway and regulating transporter mediated drug efflux.
    Chen C; Ai QD; Wei YH
    J Ethnopharmacol; 2021 Jan; 264():113388. PubMed ID: 32918990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydroxytyrosol protects against cisplatin-induced nephrotoxicity via attenuating CKLF1 mediated inflammation, and inhibiting oxidative stress and apoptosis.
    Chen C; Ai Q; Wei Y
    Int Immunopharmacol; 2021 Jul; 96():107805. PubMed ID: 34162164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kanglaite stimulates anticancer immune responses and inhibits HepG2 cell transplantation‑induced tumor growth.
    Huang X; Qin J; Lu S
    Mol Med Rep; 2014 Oct; 10(4):2153-9. PubMed ID: 25119060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor activity and immunomodulatory effects of the intraperitoneal administration of Kanglaite in vivo in Lewis lung carcinoma.
    Pan P; Wu Y; Guo ZY; Wang R; Wang YJ; Yuan YF
    J Ethnopharmacol; 2012 Sep; 143(2):680-5. PubMed ID: 22867634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of nuclear factor κB transcription activity drives a synergistic effect of cisplatin and oridonin on HepG2 human hepatocellular carcinoma cells.
    Dong X; Liu F; Li M
    Anticancer Drugs; 2016 Apr; 27(4):286-99. PubMed ID: 26704389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liquiritin inhibits proliferation and induces apoptosis in HepG2 hepatocellular carcinoma cells via the ROS-mediated MAPK/AKT/NF-κB signaling pathway.
    Wang JR; Li TZ; Wang C; Li SM; Luo YH; Piao XJ; Feng YC; Zhang Y; Xu WT; Zhang Y; Zhang T; Wang SN; Xue H; Wang HX; Cao LK; Jin CH
    Naunyn Schmiedebergs Arch Pharmacol; 2020 Oct; 393(10):1987-1999. PubMed ID: 31956937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CKLF1 Enhances Inflammation-Mediated Carcinogenesis and Prevents Doxorubicin-Induced Apoptosis via IL6/STAT3 Signaling in HCC.
    Liu Y; Liu L; Zhou Y; Zhou P; Yan Q; Chen X; Ding S; Zhu F
    Clin Cancer Res; 2019 Jul; 25(13):4141-4154. PubMed ID: 30918019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergism of cisplatin-oleanolic acid co-loaded calcium carbonate nanoparticles on hepatocellular carcinoma cells for enhanced apoptosis and reduced hepatotoxicity.
    Khan MW; Zhao P; Khan A; Raza F; Raza SM; Sarfraz M; Chen Y; Li M; Yang T; Ma X; Xiang G
    Int J Nanomedicine; 2019; 14():3753-3771. PubMed ID: 31239661
    [No Abstract]   [Full Text] [Related]  

  • 9. DNA-PKcs deficiency sensitizes the human hepatoma HepG2 cells to cisplatin and 5-fluorouracil through suppression of the PI3K/Akt/NF-κB pathway.
    Fang Y; Chai Z; Wang D; Kuang T; Wu W; Lou W
    Mol Cell Biochem; 2015 Jan; 399(1-2):269-78. PubMed ID: 25348361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cisplatin and curcumin co-loaded nano-liposomes for the treatment of hepatocellular carcinoma.
    Cheng Y; Zhao P; Wu S; Yang T; Chen Y; Zhang X; He C; Zheng C; Li K; Ma X; Xiang G
    Int J Pharm; 2018 Jul; 545(1-2):261-273. PubMed ID: 29730175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ZHX2 enhances the cytotoxicity of chemotherapeutic drugs in liver tumor cells by repressing MDR1 via interfering with NF-YA.
    Ma H; Yue X; Gao L; Liang X; Yan W; Zhang Z; Shan H; Zhang H; Spear BT; Ma C
    Oncotarget; 2015 Jan; 6(2):1049-63. PubMed ID: 25473899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemokine-like factor 1 (CKLF1) aggravates neointimal hyperplasia through activating the NF-κB /VCAM-1 pathway.
    Liu X; Qu C; Zhang Y; Fang J; Teng L; Zhang R; Zhang X; Shen C
    FEBS Open Bio; 2020 Sep; 10(9):1880-1890. PubMed ID: 32741140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dexamethasone enhances trichosanthin-induced apoptosis in the HepG2 hepatoma cell line.
    Li M; Chen F; Liu CP; Li DM; Li X; Wang C; Li JC
    Life Sci; 2010 Jan; 86(1-2):10-6. PubMed ID: 19891978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of the JNK signaling pathway increases sensitivity of hepatocellular carcinoma cells to cisplatin by down-regulating expression of P-glycoprotein.
    Liu XY; Liu SP; Jiang J; Zhang X; Zhang T
    Eur Rev Med Pharmacol Sci; 2016; 20(6):1098-108. PubMed ID: 27049263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CKLF1 aggravates neointimal hyperplasia by inhibiting apoptosis of vascular smooth muscle cells through PI3K/AKT/NF-κB signaling.
    Duan Y; Zhang Y; Qu C; Yu W; Tana ; Shen C
    Biomed Pharmacother; 2019 Sep; 117():108986. PubMed ID: 31387172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of NF-kappaB activation in the apoptosis induced by extracellular adenosine in human hepatocellular carcinoma HepG2 cells.
    Wu LF; Li GP; Su JD; Pu ZJ; Feng JL; Ye YQ; Wei BL
    Biochem Cell Biol; 2010 Aug; 88(4):705-14. PubMed ID: 20651843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kanglaite sensitizes colorectal cancer cells to Taxol via NF-κΒ inhibition and connexin 43 upregulation.
    Wang Y; Zhang C; Zhang S; Zhao Z; Wang J; Song J; Wang Y; Liu J; Hou S
    Sci Rep; 2017 Apr; 7(1):1280. PubMed ID: 28455529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of Apoptosis by Berberine in Hepatocellular Carcinoma HepG2 Cells via Downregulation of NF-κB.
    Li M; Zhang M; Zhang ZL; Liu N; Han XY; Liu QC; Deng WJ; Liao CX
    Oncol Res; 2017 Jan; 25(2):233-239. PubMed ID: 28277195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gambogic acid synergistically potentiates cisplatin-induced apoptosis in non-small-cell lung cancer through suppressing NF-κB and MAPK/HO-1 signalling.
    Wang LH; Li Y; Yang SN; Wang FY; Hou Y; Cui W; Chen K; Cao Q; Wang S; Zhang TY; Wang ZZ; Xiao W; Yang JY; Wu CF
    Br J Cancer; 2014 Jan; 110(2):341-52. PubMed ID: 24300974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic antiproliferative effects of curcumin and celecoxib in hepatocellular carcinoma HepG2 cells.
    Abdallah FM; Helmy MW; Katary MA; Ghoneim AI
    Naunyn Schmiedebergs Arch Pharmacol; 2018 Dec; 391(12):1399-1410. PubMed ID: 30155693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.